LONDON, Nov. 12, 2018 /PRNewswire/ -- This report offers an eight year forecast on the global immune repertoire sequencing market. The primary objective of the report is to offer updates and information related to the opportunities in the immune repertoire sequencing market.

Download the full report: https://www.reportbuyer.com/product/5609138

Report Description
In terms of revenue, the global immune repertoire sequencing market is expected to register a CAGR of 7.3% during the forecast period, 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global immune repertoire sequencing market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for the companies operating in the global immune repertoire sequencing market are presented in the report.

The global market for immune repertoire sequencing is expected to witness high growth in terms of value in Asian countries due to substantial price drop in sequencing platforms and integration of new technologies in biomedical research including advancement in genome sequencing. In addition, increasing international collaboration in immune repertoire sequencing projects by other developing nations is also expected to drive the growth of the immune repertoire sequencing market.

The report includes immune repertoire sequencing component types such as assay kits, software (including software integrated system platforms) and services.However, the report does not include revenue generated by the instruments or devices (running without integrated software) and accessories incurred in various academic institutions and research centres.

Revenues of third-party service vendors or representatives of primary service providers are excluded in the report. Besides, the currency fluctuations and inflation are not considered while calculating the revenue of the global immune repertoire sequencing market.

To understand and assess the opportunities in this market, the report offers the market forecast on the basis of segment type classified into the component type, application, end users and regions. The report provides analysis of the global immune repertoire sequencing market in terms of market value (US$ Mn).

By component type, the global immune repertoire sequencing market is segmented into:
Assay Kits
TCR Kits
BCR Kits
Software & Services
Analytical Software
Sequencing Services
Data Analysis Services
The report begins with the definition of immune repertoire sequencing, followed by definitions of different product types. The market dynamics section includes PMR's analysis on the key trends, drivers, restraints, opportunities, macro-economic factors and key market strategies influencing the growth of the global immune repertoire sequencing market.

The report analyses the immune repertoire sequencing market on the basis of application type and end users and presents forecast in terms of value for the next 10 years. On the basis of application, the global immune repertoire sequencing market is segmented into:

Biomarker Discovery
Infectious Diseases
Vaccine Development and efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant Rejection and Tolerance
Others
On the basis of the end users, the global immune repertoire sequencing market is segmented into:
Academic Institutes
Research Centers Diagnostic laboratories
Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of region, the global immune repertoire sequencing market is segmented into:

North America
U.S.
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
Germany
France
U.K.
Italy
Spain
Poland
Russia
Rest of Eastern Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia- Pacific
Middle East & Africa (MEA)
GCC countries
South Africa
Rest of Middle East and Africa
In addition, we have considered the Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global immune repertoire sequencing market.

Another key feature of this report is the analysis of the key segments in immune repertoire sequencing market in terms of absolute dollar opportunity.This is usually overlooked while forecasting the market.

However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered in the global immune repertoire sequencing market.To understand the key segments in terms of their growth and performance in the global immune repertoire sequencing market, PMR has developed a market attractiveness index.

The resulting index will help identify the existing opportunities in the global immune repertoire sequencing market.

In the final section of the report, the 'competitive landscape' has been included to provide a dashboard view of the key companies operating in the global immune repertoire sequencing market.This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key provider's specific to a market segment in the global immune repertoire sequencing market.

However, this section also includes market strategies and SWOT analysis of the key players operating in the global immune repertoire sequencing market.

Detailed profiles of the assay kit manufacturers, software and service providers of immune repertoire sequencing are also included in the scope of the report to evaluate their long- and short-term strategies.Examples of some of the key players operating in the global immune repertoire sequencing market are Illumina, Takara Bio Inc, BGI, Thermo Fischer Scientific, and F.

Hoffmann-La Roche Ltd, among others.

Download the full report: https://www.reportbuyer.com/product/5609138

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/global-market-study-on-immune-repertoire-sequencing-research-center-end-use-segment-to-hold-significant-revenue-share-through-2026-owing-to-increased-focus-on-cancer-immunotherapy-research-300748411.html

SOURCE ReportBuyer